ArticleNPJ breast cancer2026

Programmable local immunochemotherapy for triple-negative breast cancer via spatiotemporally controlled release of CpG oligodeoxynucleotides, gemcitabine, and paclitaxel.

Cheng-Hsien Hsieh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.